Genome profiling of ERBB2-amplified breast cancers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Genome profiling of ERBB2-amplified breast cancers ; volume:10 ; number:1 ; day:8 ; month:10 ; year:2010 ; pages:1-18 ; date:12.2010
BMC cancer ; 10, Heft 1 (8.10.2010), 1-18, 12.2010

Creator: Sircoulomb, Fabrice

Contributor: Bekhouche, Ismahane
Finetti, Pascal
Adélaïde, José
Hamida, Azza Ben
Bonansea, Julien
Raynaud, Stéphane
Innocenti, Charlène
Charafe-Jauffret, Emmanuelle
Tarpin, Carole
Ayed, Farhat Ben
Viens, Patrice
Jacquemier, Jocelyne
Bertucci, François
Birnbaum, Daniel
Chaffanet, Max
SpringerLink (Online service)

DOI: 10.1186/1471-2407-10-539

URN: urn:nbn:de:1111-2016030357105

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Sircoulomb, Fabrice
Bekhouche, Ismahane
Finetti, Pascal
Adélaïde, José
Hamida, Azza Ben
Bonansea, Julien
Raynaud, Stéphane
Innocenti, Charlène
Charafe-Jauffret, Emmanuelle
Tarpin, Carole
Ayed, Farhat Ben
Viens, Patrice
Jacquemier, Jocelyne
Bertucci, François
Birnbaum, Daniel
Chaffanet, Max
SpringerLink (Online service)

Other Objects (12)

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Noten (Musik)

Amplified imagination

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Noten (Musik)

Amplified imagination

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Noten (Musik)

Amplified imagination

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Genome profiling of ERBB2-amplified breast cancers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Amplified imagination

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Amplified imagination

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing

Transcriptome and genome evolution during HER2-amplified breast neoplasia

ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

Variant discovery in targeted resequencing using whole genome amplified DNA

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness

Amplified imagination

Related objects

Reset password